The end-stage renal disease is characterized by a profound impairment in the regulation of body fluid distribution, and volume assessment in hemodialysis is one of the challenging goals for the nephrologist. To determine a state of euvolemia, different validated techniques have been employed and among them lung ultrasonography (LUS) has recently attracted growing attention on account of its capacity to estimate accurately extra vascular lung water and to detect lung edema even in its early asymptomatic stage, that is, hidden lung congestion.With its noninvasiveness, freedom from radiation, the ease of use, acceptable intra/inter-operator reproducibility and availability of portable ultrasound devices, LUS can be considered one of the most interesting “cards to play” for the volume assessment in patients on hemodialysis.

Keywords:
Hemodialysis, Dry weight, Lung interstitial syndrome, Lung ultrasound
1.
Hecking M, Rayner H, Wabel P: What are the consequences of volume expansion in chronic dialysis patients?: defining and measuring fluid overload in hemodialysis patients. Semin Dial 2015;28:242-247.
2.
Ronco C, Kaushik M, Valle R, Aspromonte N, Peacock WF 4th: Diagnosis and management of fluid overload in heart failure and cardio-renal syndrome: the “5B” approach. Semin Nephrol 2012;32:129-141.
3.
Ross DW, Barnett RL, Shah HH: Lung ultrasonography: a novel clinical tool to consider in nephrology. Kidney Int 2016;89:720-721.
4.
Volpicelli G, Elbarbary M, Blaivas M, et al; International Liaison Committee on Lung Ultrasound (ILC-LUS) for International Consensus Conference on Lung Ultrasound (ICC-LUS): International evidence-based recommendations for point-of-care lung ultrasound. Intensive Care Med 2012;38:577-591.
5.
Ziskin MC, Thickman DI, Goldenberg NJ, Lapayowker MS, Becker JM: The comet tail artifact. J Ultrasound Med 1982;1:1-7.
6.
Lichtenstein D, Mézière G, Biderman P, Gepner A, Barré O: The comet-tail artifact. An ultrasound sign of alveolar-interstitial syndrome. Am J Respir Crit Care Med 1997;156:1640-1646.
7.
Picano E, Frassi F, Agricola E, Gligorova S, Gargani L, Mottola G: Ultrasound lung comets: a clinically useful sign of extravascular lung water. J Am Soc Echocardiogr 2006;19:356-363.
8.
Mallamaci F, Benedetto FA, Tripepi R, et al: Detection of pulmonary congestion by chest ultrasound in dialysis patients. JACC Cardiovasc Imaging 2010;3:586-594.
9.
Soldati G, Copetti R, Sher S: Can lung comets be counted as “objects”? JACC Cardiovasc Imaging 2011;4:438-439.
10.
Picano E, Pellikka PA: Ultrasound of extravascular lung water: a new standard for pulmonary congestion. Eur Heart J 2016;37:2097-2104.
11.
Spinelli A, Vinci B, Tirella A, et al: Realization of a poro-elastic ultrasound replica of pulmonary tissue. Biomatter 2012;2:37-42.
12.
Volpicelli G, Mussa A, Garofalo G, et al: Bedside lung ultrasound in the assessment of alveolar-interstitial syndrome. Am J Emerg Med 2006;24:689-696.
13.
Jambrik Z, Monti S, Coppola V, et al: Usefulness of ultrasound lung comets as a nonradiologic sign of extravascular lung water. Am J Cardiol 2004;93:1265-1270.
14.
Gargani L, Volpicelli G: How I do it: lung ultrasound. Cardiovasc Ultrasound 2014;12:25.
15.
Weitzel WF, Hamilton J, Wang X, et al: Quantitative lung ultrasound comet measurement: method and initial clinical results. Blood Purif 2015;39:37-44.
16.
Lichtenstein DA: Lung ultrasound in the critically ill. Ann Intensive Care 2014;4:1.
17.
Frassi F, Gargani L, Tesorio P, Raciti M, Mottola G, Picano E: Prognostic value of extravascular lung water assessed with ultrasound lung comets by chest sonography in patients with dyspnea and/or chest pain. J Card Fail 2007;13:830-835.
18.
Cogliati C, Casazza G, Ceriani E, et al: Lung ultrasound and short-term prognosis in heart failure patients. Int J Cardiol 2016;218:104-108.
19.
Enghard P, Rademacher S, Nee J, et al: Simplified lung ultrasound protocol shows excellent prediction of extravascular lung water in ventilated intensive care patients. Crit Care 2015;19:36.
20.
Ozkahya M, Ok E, Toz H, et al: Long-term survival rates in haemodialysis patients treated with strict volume control. Nephrol Dial Transplant 2006;21:3506-3513.
21.
Kalantar-Zadeh K, Regidor DL, Kovesdy CP, et al: Fluid retention is associated with cardiovascular mortality in patients undergoing long-term hemodialysis. Circulation 2009;119:671-679.
22.
Palmer BF, Henrich WL: Recent advances in the prevention and management of intradialytic hypotension. J Am Soc Nephrol 2008;19:8-11.
23.
Torino C, Gargani L, Sicari R, et al: The agreement between auscultation and lung ultrasound in hemodialysis patients: the LUST study. Clin J Am Soc Nephrol 2016;11:2005-2011.
24.
Maines M, Catanzariti D, Angheben C, et al: Intrathoracic impedance and ultrasound lung comets in heart failure deterioration monitoring. Pacing Clin Electrophysiol 2011;34:968-974.
25.
Zoccali C, Tripepi R, Torino C, Bellantoni M, Tripepi G, Mallamaci F: Lung congestion as a risk factor in end-stage renal disease. Blood Purif 2013;36:184-191.
26.
Noble VE, Murray AF, Capp R, Sylvia-Reardon MH, Steele DJ, Liteplo A: Ultrasound assessment for extravascular lung water in patients undergoing hemodialysis. Time course for resolution. Chest 2009;135:1433-1439.
27.
Di Iorio BR, Scalfi L, Terracciano V, Bellizzi V: A systematic evaluation of bioelectrical impedance measurement after hemodialysis session. Kidney Int 2004;65:2435-2440.
28.
Basso F, Milan Manani S, Cruz DN, et al: Comparison and reproducibility of techniques for fluid status assessment in chronic hemodialysis patients. Cardiorenal Med 2013;3:104-112.
29.
Siriopol D, Hogas S, Voroneanu L, et al: Predicting mortality in haemodialysis patients: a comparison between lung ultrasonography, bioimpedance data and echocardiography parameters. Nephrol Dial Transplant 2013;28:2851-2859.
30.
Zoccali C, Torino C, Tripepi R, et al: Pulmonary congestion predicts cardiac events and mortality in ESRD. J Am Soc Nephrol 2013;24:639-646.
31.
Marino F, Martorano C, Tripepi R, et al: Subclinical pulmonary congestion is prevalent in nephrotic syndrome. Kidney Int 2016;89:421-428.
32.
Panuccio V, Enia G, Tripepi R, et al: Chest ultrasound and hidden lung congestion in peritoneal dialysis patients. Nephrol Dial Transplant 2012;27:3601-3605.
33.
Enia G, Torino C, Panuccio V, et al: Asymptomatic pulmonary congestion and physical functioning in hemodialysis patients. Clin J Am Soc Nephrol 2013;8:1343-1348.
34.
Enia G, Tripepi R, Panuccio V, et al: Pulmonary congestion and physical functioning in peritoneal dialysis patients. Perit Dial Int 2012;32:531-536.
35.
Zoccali C, Benedetto FA, Mallamaci F, et al: Prognostic value of echocardiographic indicators of left ventricular systolic function in asymptomatic dialysis patients. J Am Soc Nephrol 2004;15:1029-1037.
36.
Hasuike Y, Nonoguchi H, Ito K, et al: Interleukin-6 is a predictor of mortality in stable hemodialysis patients. Am J Nephrol 2009;30:389-398.
37.
Scheel PJ, Liu M, Rabb H: Uremic lung: new insights into a forgotten condition. Kidney Int 2008;74:849-851.
38.
Sherman RA: Crackles and comets: lung ultrasound to detect pulmonary congestion in patients on dialysis is coming of age. Clin J Am Soc Nephrol 2016;11:1924-1926.
© 2017 S. Karger AG, Basel
2017
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.